PL3594199T3 - Krystaliczny 2-fluoro-3-nitrotoluen i sposób jego wytwarzania - Google Patents
Krystaliczny 2-fluoro-3-nitrotoluen i sposób jego wytwarzaniaInfo
- Publication number
- PL3594199T3 PL3594199T3 PL18182368T PL18182368T PL3594199T3 PL 3594199 T3 PL3594199 T3 PL 3594199T3 PL 18182368 T PL18182368 T PL 18182368T PL 18182368 T PL18182368 T PL 18182368T PL 3594199 T3 PL3594199 T3 PL 3594199T3
- Authority
- PL
- Poland
- Prior art keywords
- nitrotoluene
- fluoro
- crystalline
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18182368.3A EP3594199B1 (en) | 2018-07-09 | 2018-07-09 | Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3594199T3 true PL3594199T3 (pl) | 2020-11-16 |
Family
ID=62904314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL18182368T PL3594199T3 (pl) | 2018-07-09 | 2018-07-09 | Krystaliczny 2-fluoro-3-nitrotoluen i sposób jego wytwarzania |
Country Status (17)
Country | Link |
---|---|
US (1) | US20210292271A1 (pl) |
EP (1) | EP3594199B1 (pl) |
JP (1) | JP7407166B2 (pl) |
CN (1) | CN112654602A (pl) |
AU (1) | AU2019303323B2 (pl) |
CA (1) | CA3105559A1 (pl) |
CY (1) | CY1123514T1 (pl) |
DK (1) | DK3594199T3 (pl) |
ES (1) | ES2815899T3 (pl) |
HR (1) | HRP20201198T1 (pl) |
HU (1) | HUE052049T2 (pl) |
LT (1) | LT3594199T (pl) |
MX (1) | MX2021000348A (pl) |
PL (1) | PL3594199T3 (pl) |
PT (1) | PT3594199T (pl) |
SI (1) | SI3594199T1 (pl) |
WO (1) | WO2020011626A1 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY35449A (es) | 2013-03-14 | 2014-09-30 | Amgen Inc | Compuestos heterocíclicos y sus usos |
SI3645518T1 (sl) | 2017-06-30 | 2021-11-30 | Amgen Inc. | Sinteza omekamtiv mekarbila |
BR112019028046A2 (pt) | 2017-06-30 | 2020-07-07 | Amgen Inc. | métodos de tratamento da insuficiência cardíaca com ativadores de sarcômeros cardíacos |
EP3681882A1 (en) | 2017-09-13 | 2020-07-22 | Amgen Inc. | Bisamide sarcomere activating compounds and uses thereof |
MX2021001792A (es) | 2018-08-17 | 2021-05-27 | Amgen Inc | Sales y formas cristalinas de omecamtiv mecarbil. |
MX2023010558A (es) | 2021-03-10 | 2023-11-24 | Amgen Inc | Sintesis de omecamtiv mecarbil. |
WO2024081611A1 (en) | 2022-10-11 | 2024-04-18 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR059339A1 (es) * | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
CN101177400A (zh) | 2006-11-06 | 2008-05-14 | 吕铁环 | 一种生产2-氟-3-硝基甲苯的方法 |
US8569378B2 (en) | 2007-07-20 | 2013-10-29 | Toshiyuki Sakai | p27 protein inducer |
TWI648273B (zh) * | 2013-02-15 | 2019-01-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺類(三) |
UY35449A (es) | 2013-03-14 | 2014-09-30 | Amgen Inc | Compuestos heterocíclicos y sus usos |
-
2018
- 2018-07-09 HU HUE18182368A patent/HUE052049T2/hu unknown
- 2018-07-09 LT LTEP18182368.3T patent/LT3594199T/lt unknown
- 2018-07-09 ES ES18182368T patent/ES2815899T3/es active Active
- 2018-07-09 SI SI201830120T patent/SI3594199T1/sl unknown
- 2018-07-09 DK DK18182368.3T patent/DK3594199T3/da active
- 2018-07-09 PL PL18182368T patent/PL3594199T3/pl unknown
- 2018-07-09 PT PT181823683T patent/PT3594199T/pt unknown
- 2018-07-09 EP EP18182368.3A patent/EP3594199B1/en active Active
-
2019
- 2019-07-03 CN CN201980058205.6A patent/CN112654602A/zh active Pending
- 2019-07-03 WO PCT/EP2019/067894 patent/WO2020011626A1/en active Application Filing
- 2019-07-03 CA CA3105559A patent/CA3105559A1/en active Pending
- 2019-07-03 JP JP2021500471A patent/JP7407166B2/ja active Active
- 2019-07-03 MX MX2021000348A patent/MX2021000348A/es unknown
- 2019-07-03 AU AU2019303323A patent/AU2019303323B2/en active Active
- 2019-07-03 US US17/258,385 patent/US20210292271A1/en active Pending
-
2020
- 2020-07-30 HR HRP20201198TT patent/HRP20201198T1/hr unknown
- 2020-09-15 CY CY20201100873T patent/CY1123514T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA3105559A1 (en) | 2020-01-16 |
HUE052049T2 (hu) | 2021-04-28 |
AU2019303323B2 (en) | 2024-08-22 |
US20210292271A1 (en) | 2021-09-23 |
EP3594199A1 (en) | 2020-01-15 |
AU2019303323A1 (en) | 2021-01-28 |
CN112654602A (zh) | 2021-04-13 |
CY1123514T1 (el) | 2022-03-24 |
HRP20201198T1 (hr) | 2020-11-13 |
MX2021000348A (es) | 2021-06-08 |
EP3594199B1 (en) | 2020-07-01 |
SI3594199T1 (sl) | 2020-10-30 |
DK3594199T3 (da) | 2020-09-14 |
JP7407166B2 (ja) | 2023-12-28 |
JP2021532076A (ja) | 2021-11-25 |
WO2020011626A1 (en) | 2020-01-16 |
ES2815899T3 (es) | 2021-03-31 |
PT3594199T (pt) | 2020-09-04 |
LT3594199T (lt) | 2020-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202108603B (en) | Rip1 inhibitory compounds and methods for making and using the same | |
IL276917A (en) | A process for the preparation of alubixivet | |
ZA202007487B (en) | Rip1 inhibitory compounds and methods for making and using the same | |
PL3594199T3 (pl) | Krystaliczny 2-fluoro-3-nitrotoluen i sposób jego wytwarzania | |
PT3580219T (pt) | Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam | |
GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
HUE063118T2 (hu) | Eljárás N-alkil-nitrátoetilnitraminok elõállítására | |
IL289453A (en) | A process for the preparation of ridinilazole and crystalline forms thereof | |
SG11202013126QA (en) | NOVEL HYDROXYPROPYL-ß-CYCLODEXTRIN AND PROCESS FOR THE PRODUCTION THEREOF | |
IL281254A (en) | A process for the preparation of lanbatinib | |
EP3877361C0 (en) | PROCESS FOR PREPARING ARYLSULFONYLPROPENENITRILE | |
EP3564219A4 (en) | PROCESS FOR PREPARING AN OXADIAZACYCLO COMPOUND AND THEIR USE | |
PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
GB201818028D0 (en) | Crystalline materials | |
GB201816445D0 (en) | Crystalline materials | |
GB2555866B (en) | A novel crystalline form of epocholeone, a process for its preparation and use the same | |
HUP1800397A2 (en) | Process for the preparation of lumateperone and salts thereof | |
HUP1800278A2 (en) | Process for the preparation of boc-linagliptin | |
HUE053318T2 (hu) | Lubiproszton kristályok és azok elõállítása | |
IL276108A (en) | Crystalline forms of psoorstam | |
EP3704109C0 (en) | PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM III OF TIPIRACIL HYDROCHLORIDE | |
PL3704100T3 (pl) | Nowy sposób wytwarzania tawaborolu i jego związków pośrednich |